Treatment of Nondiabetic Kidney Diseases with Sodium-Glucose Cotransporter-2 Inhibitors

Clin J Am Soc Nephrol. 2023 Oct 1;18(10):1359-1361. doi: 10.2215/CJN.0000000000000194. Epub 2023 May 10.

Author

Frank C Brosius^{1

2}

Affiliations

¹ Department of Medicine, University of Arizona, Tucson, AZ.
² Departments of Internal Medicine and Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI.

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucose
Humans
Hypoglycemic Agents / therapeutic use
Kidney
Kidney Diseases* / drug therapy
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors
Hypoglycemic Agents
Glucose
Sodium